Stay updated on GP2013 in Previously Untreated Advanced Follicular Lymphoma: Clinical Trial

Sign up to get notified when there's something new on the GP2013 in Previously Untreated Advanced Follicular Lymphoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GP2013 in Previously Untreated Advanced Follicular Lymphoma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in data related to the comparability of ORR in patients with previously untreated, advanced stage Follicular Lymphoma receiving GP2013-treatment versus MabThera-treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:44:43.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying inclusion and exclusion criteria for patients with previously untreated advanced stage, CD20-positive follicular lymphoma. This change provides more specific information about the health conditions and prior treatments that qualify or disqualify potential participants.
    Difference
    10%
    Check dated 2024-05-22T21:27:07.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:21:51.000Z thumbnail image

Stay in the know with updates to GP2013 in Previously Untreated Advanced Follicular Lymphoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GP2013 in Previously Untreated Advanced Follicular Lymphoma: Clinical Trial page.